Urofollitropin biosimilar (Amega Biotech)

尿促卵泡素生物类似药 (Amega Biotech)

Report date: 2022/03/21 15:56:29

Base Information

Drug NameUrofollitropin biosimilar (Amega Biotech)

Drug Alias Name尿促卵泡素生物仿制药 (Amega Biotech)FSH biosimilar

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar

Mechanisms of ActionFollicle-stimulating hormone receptor agonists

TargetsFollicle-stimulating hormone receptor

Therapy Area/IndicationsInfertility, FemaleInfertility, Male

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesAmega Biotech

China Registration ClassN/A

Active CompaniesAmega Biotech

Inactive CompaniesN/A

Active IndicationsInfertility, FemaleInfertility, Male

Inactive IndicationsN/A

ATC CodeG03GA04